Studying the multiple mutation of DAT residues in Tat-DAT intermolecular interaction will greatly contribute to our ongoing proof of concept studies using novel allosteric modulators to establish their potential for therapeutic application in HAND. This evidence concerns the gene SLC6A3 and HIV-associated neurocognitive disorder.